REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 15th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made as of July 13, 2020, by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and entities controlled by Pillar Invest Corporation, Cayman Islands limited partnerships, set forth on Schedule A hereto (each an “Investor” and together the “Investors”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 15th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of July 13, 2020 (the “Effective Date”) by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and entities controlled by Pillar Invest Corporation, Cayman Islands limited partnerships, set forth on Schedule A hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
